To test the impact of a hyperglycemic tumor microenvironments on OGT, we used B6.Rag1 knockout mice, an obesity-compatible mouse model [65], to measure effects in TNBC tumors (Fig. 7a). The gene discussed is RAG1; the disease is obesity due to melanocortin 4 receptor deficiency.